SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

NCT00002548 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

899

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: carmustine
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: melphalan
DRUG: prednisone
DRUG: vincristine sulfate
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]